Cancer Plus
Electronic ISSN: 2661-3840
Print ISSN: 2661-3832
Editors-in-Chief: Thomas Efferth, Xiansheng Liu View Editorial Board

Cancer Plus is a research journal dedicated to the publication of findings in cancer research.  This journal is a joint collaboration between Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital (China), and the Chinese Academy of Sciences.

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. research papers, clinical research reports, review articles.

ORIGINAL RESEARCH ARTICLE

MiR-381-3p/TET3 axis promotes cervical cancer: A bioinformatic integrative analysis

Hilda Jiménez Wences, Pedro Antonio Ávila López, Gabriela Elizabeth Campos Viguri, Ana Elvira Zacapala Gómez, ... Eric Genaro Salmerón Bárcenas
CP, 3884
CASE REPORT

A rare case report of paratesticular leiomyosarcoma

Santosh Nimkar, Bianca Glass, Samir Dalia
CP, 3971
Special Issues

Emerging Biomarkers for Endometrial Cancer Diagnosis and Prognosis

Guest Editors: Giuseppe Gullo, Valentina Billone, Gaspare Cucinella
Submission deadline: 15 May 2025

Stromal Cells in the Tumor Environment

Guest Editors: Veronka Lukacs-Kornek, Jian Li
Submission deadline: 15 March 2025

Advances in Bone Metastasis Management

Guest Editor: Andrea Sambri
Submission deadline: 15 October 2024
News and Announcements
Share
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing